Slate Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLATE, and what generic and branded alternatives to SLATE drugs are available?
SLATE has seventeen approved drugs.
Drugs and US Patents for Slate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slate Run Pharma | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 212091-005 | Dec 28, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slate Run Pharma | DROXIDOPA | droxidopa | CAPSULE;ORAL | 215265-001 | Nov 1, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slate Run Pharma | METHOCARBAMOL | methocarbamol | SOLUTION;IM-IV | 208116-001 | Jan 19, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.